vTv Therapeutics Inc. [NASDAQ: VTVT] stock went on an upward path that rose over 0.50% on Monday, amounting to a one-week price decrease of less than -8.58%. Over the last 12 months, VTVT stock rose by 99.28%. The average equity rating for VTVT stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $180.52 million, with 43.46 million shares outstanding and 9.80 million shares in the current float. Compared to the average trading volume of 288.99K shares, VTVT stock reached a trading volume of 2733806 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on vTv Therapeutics Inc. [VTVT]:
H.C. Wainwright have made an estimate for vTv Therapeutics Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 30, 2019. While these analysts kept the previous recommendation, Stifel dropped their target price from $12 to $1. The new note on the price target was released on April 10, 2018, representing the official price target for vTv Therapeutics Inc. stock. Previously, the target price had yet another raise to $17, while ROTH Capital analysts kept a Buy rating on VTVT stock.
The Average True Range (ATR) for vTv Therapeutics Inc. is set at 0.25, with the Price to Sales ratio for VTVT stock in the period of the last 12 months amounting to 95.01.
VTVT Stock Performance Analysis:
vTv Therapeutics Inc. [VTVT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.58. With this latest performance, VTVT shares dropped by -8.58% in over the last four-week period, additionally plugging by 82.84% over the last 6 months – not to mention a rise of 99.28% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VTVT stock in for the last two-week period is set at 49.92, with the RSI for the last a single of trading hit 47.35, and the three-weeks RSI is set at 53.14 for vTv Therapeutics Inc. [VTVT]. The present Moving Average for the last 50 days of trading for this stock 2.49, while it was recorded at 2.80 for the last single week of trading, and 2.03 for the last 200 days.
Insight into vTv Therapeutics Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and vTv Therapeutics Inc. [VTVT] shares currently have an operating margin of -755.86. vTv Therapeutics Inc.’s Net Margin is presently recorded at -648.08.
Reflecting on the efficiency of the workforce at the company, vTv Therapeutics Inc. [VTVT] managed to generate an average of -$688,962 per employee. Receivables Turnover for the company is 1,105.60 with a Total Asset Turnover recorded at a value of 0.31.vTv Therapeutics Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.30 and a Current Ratio set at 0.30.
VTVT Stock EPS
With the latest financial reports released by the company, vTv Therapeutics Inc. posted -0.15/share EPS, while the average EPS was predicted by analysts to be reported at -0.11/share.When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -36.40%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VTVT.
vTv Therapeutics Inc. [VTVT] Insider Position Details
There are presently around $15 million, or 12.50% of VTVT stock, in the hands of institutional investors. The top three institutional holders of VTVT stocks are: ROYAL BANK OF CANADA with ownership of 3,250,471, which is approximately 984891.212% of the company’s market cap and around 0.10% of the total institutional ownership; FRAZIER MANAGEMENT LLC, holding 1,062,000 shares of the stock with an approximate value of $2.93 million in VTVT stocks shares; and VANGUARD GROUP INC, currently with $0.85 million in VTVT stock with ownership of nearly 29.011% of the company’s market capitalization.
Positions in vTv Therapeutics Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 16 institutional holders increased their position in vTv Therapeutics Inc. [NASDAQ:VTVT] by around 5,007,455 shares. Additionally, 10 investors decreased positions by around 376,950 shares, while 3 investors held positions by with 190,073 shares. The mentioned changes placed institutional holdings at 5,574,478 shares, according to the latest SEC report filing. VTVT stock had 10 new institutional investments in for a total of 1,242,518 shares, while 3 institutional investors sold positions of 113,300 shares during the same period.